Propiedad y actividad de insiders de Absci Corporation (ABSI): operaciones de insiders, transacciones del Senado y la Cámara de EE. UU. y acciones en circulación. Sigue cómo operan la acción los directivos y los políticos.
Precio
| Precio | $8.04 |
| Capitalización | $1.4B |
| Bolsa | NASDAQ |
| País | US |
Operaciones Recientes de Insiders
| Fecha | Insider | Tipo | Acciones | Valor |
|---|---|---|---|---|
| 2026-08-31 | Jonasson Zachariah | F-InKind | 8,320 | $72K |
| 2026-03-03 | Somaratne Ransi Mudalinayake | A-Award | 650,000 | $1.7M |
| 2026-08-03 | Somaratne Ransi Mudalinayake | A-Award | 383,000 | $3.0M |
| 2026-03-03 | Somaratne Ransi Mudalinayake | |||
| 2026-06-30 | Szela Mary T | P-Purchase | 12,900 | $149K |
| 2026-06-24 | McClain Sean | F-InKind | 59,896 | $603K |
| 2026-06-04 | Szela Mary T | A-Award | 33,200 | $244K |
| 2026-06-04 | Szela Mary T | A-Award | 8,400 | |
| 2026-06-04 | MCGINNIS KAREN K | A-Award | 10,100 | |
| 2026-06-04 | MCGINNIS KAREN K | A-Award | 39,800 | $292K |
Balance (10 años)
| Año | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|
| Caja y Equivalentes | $13.1M | $69.9M | $252.6M | $60.0M | $72.4M | $41.2M | $20.0M |
| Inversiones a Corto | 0 | 0 | 0 | $104.5M | $25.3M | $71.2M | $124.3M |
| Cuentas por Cobrar | $222000 | $1.6M | $1.4M | $1.6M | $2.2M | 0 | 0 |
| Inventario | 0 | 0 | $10.5M | $15.0M | 0 | 0 | 0 |
| Activos Corrientes | $13.6M | $73.2M | $273.1M | $186.9M | $120.6M | $133.8M | $149.6M |
| Inmovilizado Material | $5.0M | $13.4M | $58.7M | $58.0M | $45.8M | $33.1M | $23.8M |
| Fondo de Comercio | 0 | 0 | $21.3M | $21.3M | 0 | 0 | 0 |
| Activos Intangibles | $283000 | 0 | $55.0M | $51.6M | $48.3M | $44.9M | $41.5M |
| Activos Totales | $19.5M | $88.6M | $426.2M | $321.0M | $217.3M | $213.6M | $216.3M |
| Cuentas por Pagar | $268000 | $2.1M | $8.4M | $2.4M | $1.5M | $3.5M | $2.8M |
| Deuda a Corto | $1.2M | $1.5M | $2.4M | $2.9M | $3.3M | $2.7M | $873000 |
| Pasivos Corrientes | $3.5M | $10.1M | $33.9M | $30.3M | $29.6M | $28.7M | $22.8M |
| Deuda a Largo | $1.7M | $4.1M | $1.1M | $8.0M | $4.7M | $1.3M | 0 |
| Pasivos Totales | $60.6M | $21.6M | $60.1M | $46.6M | $41.1M | $34.5M | $26.8M |
| Reservas | -$41.4M | -$90.1M | -$191.0M | -$295.9M | -$406.5M | -$509.6M | -$624.8M |
| Patrimonio Neto | -$41.2M | $67.0M | $366.1M | $274.4M | $176.2M | $179.1M | $189.4M |
| Deuda Total | $6.0M | $14.5M | $20.0M | $23.0M | $15.9M | $10.1M | $5.3M |
| Deuda Neta | -$7.1M | -$55.4M | -$232.6M | -$141.4M | -$81.8M | -$102.3M | -$139.0M |
| Capital Circulante | $10.2M | $63.1M | $239.2M | $156.6M | $91.0M | $105.2M | $126.8M |
Salud financiera
| Deuda / Patrimonio | 0.01 |
| Ratio corriente | 10.63 |
Rentabilidad
| Rentabilidad sobre capital | -59.21% |
| Rentabilidad sobre capital invertido | -52.24% |
| Rentabilidad sobre activos | -45.02% |
| Margen bruto | -255.93% |
| Margen operativo | -8411.27% |
| Margen neto | -7756.37% |
Empresas relacionadas: CRVS · ERAS · GOSS · MGTX · MLTX · OLMA · PRTA
Explorar sector: Healthcare · Biotechnology
Más secciones de ABSI: Resumen · Financieros · Valoración · Estadísticas · Estimaciones · Técnico · Noticias · Eventos
Descubre más: Radar — señales de acciones infravaloradas · Academia de Inversión — aprende a analizar acciones